Samsung Biologics expanded its partnership with LigaChem Biosciences to collaborate on projects to develop antibody-drug conjugates (ADC) for cancer treatments, the drugmaker said on Thursday.

LIBERTYVILLE, Ill., January 14, 2025--(BUSINESS WIRE)--Valent BioSciences in partnership with Meister Media Worldwide announces the launch of the Biostimulant Innovator of the Year Award for farmers.

Samsung Biologics will support a series of LigaChem Biosciences' ADC programs at Samsung Biologics' new dedicated ADC facility. The two companies have already been collaborating on ADC programs ...

Valent BioSciences is also the parent company of Mycorrhizal Applications LLC, a leading supplier of arbuscular mycorrhizal fungi-based products. For additional information, visit the company's ...

The contract development and manufacturing organization (CDMO) Samsung Biologics and the new drug development corporation LigaChem Biosciences will collaborate on more than three antibody-drug ...

INCHEON, South Korea, Jan. 9, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to extend collaboration with ...

OSAGE, Iowa (KTTC) – In northeast Iowa, Valent BioSciences continues to be a global leader in its sustainability efforts. But in Mitchell County, it’s also giving back to its community and schools ...

9, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to extend collaboration with LigaChem Biosciences ...